December 7, 2022
Beckley Psytech to participate in Canaccord Genuity’s Symposium on New Paradigms and Treatment Approaches in Mental Health - December 13, 2022
Beckley Psytech Limited, a private, clinical stage biotechnology company dedicated to addressing neuropsychiatric conditions through the novel application of psychedelic medicines, announced today that Cosmo Feilding Mellen, Chief Executive Officer and Rob Conley, Chief Scientific Officer will be a panellist at Canaccord Genuity’s Symposium on New Paradigms and Treatment Approaches in Mental Health, taking place virtually on December 13th 2022.
Read more